Literature DB >> 8638108

Blocked Ras activation in anergic CD4+ T cells.

P E Fields1, T F Gajewski, F W Fitch.   

Abstract

T cell anergy is a state of functional unresponsiveness characterized by the inability to produce interleukin-2 (IL-2) upon T cell receptor stimulation. The mitogen-activated protein kinases ERK-1 and ERK-2 and the guanosine triphosphate-binding protein p21ras were found to remain unactivated upon stimulation of anergic murine T helper cell 1 clones. The inability to activate the Ras pathway did not result from a defect in association among Shc, Grb-2, and murine Son of Sevenless, nor from a defect in their tyrosine phosphorylation. This block in Ras activation may lead to defective transactivation at activator protein 1 sites in anergic cells and may enable T cells to shut down IL-2 production selectively during anergy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638108     DOI: 10.1126/science.271.5253.1276

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  102 in total

1.  Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1.

Authors:  J Czyzyk; D Leitenberg; T Taylor; K Bottomly
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

Authors:  C J Li; Y Ueda; B Shi; L Borodyansky; L Huang; Y Z Li; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Activation of CD4 T cells by Raf-independent effectors of Ras.

Authors:  Jan Czyzyk; Jennifer L Brogdon; Abdallah Badou; Octavian Henegariu; Paula Preston Hurlburt; Richard Flavell; Kim Bottomly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

4.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 5.  Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  J Mol Med (Berl)       Date:  2006-09-14       Impact factor: 4.599

6.  T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Authors:  Meixiao Long; Aaron M Slaiby; Adam T Hagymasi; Marianne A Mihalyo; Alexander C Lichtler; Steven L Reiner; Adam J Adler
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 7.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

Review 8.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 10.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.